nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A CTL/M2 macrophage-related four-gene signature predicting metastasis-free survival in triple-negative breast cancer treated with adjuvant radiotherapy
|
Ye, Yunfei |
|
|
190 |
2 |
p. 329-341 |
artikel |
2 |
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
|
Goldstein, Lori J. |
|
|
190 |
2 |
p. 265-275 |
artikel |
3 |
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
|
Liu, Xiaoran |
|
|
190 |
2 |
p. 213-226 |
artikel |
4 |
Effects of PI3K inhibition in AI-resistant breast cancer cell lines: autophagy, apoptosis, and cell cycle progression
|
Augusto, Tiago V. |
|
|
190 |
2 |
p. 227-240 |
artikel |
5 |
Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer
|
Jiang, Rui |
|
|
190 |
2 |
p. 203-211 |
artikel |
6 |
Fatty liver disease and changes in dense breasts in pre- and postmenopausal women: the Kangbuk Samsung Health Study
|
Cho, Yoosun |
|
|
190 |
2 |
p. 343-353 |
artikel |
7 |
Genetic testing in women with early-onset breast cancer: a Traceback pilot study
|
Augustinsson, Annelie |
|
|
190 |
2 |
p. 307-315 |
artikel |
8 |
Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival
|
Giannoudis, Athina |
|
|
190 |
2 |
p. 241-253 |
artikel |
9 |
Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase
|
Capellen, Caleb C. |
|
|
190 |
2 |
p. 255-264 |
artikel |
10 |
Immediate breast reconstruction in locally advanced breast cancer: is it safe?
|
Taqi, Kadhim |
|
|
190 |
2 |
p. 175-182 |
artikel |
11 |
Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
|
Wang, Xiaofang |
|
|
190 |
2 |
p. 277-286 |
artikel |
12 |
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer
|
Haynes, Ben P. |
|
|
190 |
2 |
p. 295-305 |
artikel |
13 |
Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancer
|
Mouabbi, Jason A. |
|
|
190 |
2 |
p. 189-201 |
artikel |
14 |
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
|
Dilawari, A. |
|
|
190 |
2 |
p. 287-293 |
artikel |
15 |
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer
|
Sukumar, Jasmine S. |
|
|
190 |
2 |
p. 183-188 |
artikel |
16 |
The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI
|
Amitai, Yoav |
|
|
190 |
2 |
p. 317-327 |
artikel |